Clinical trials for HIV/AIDS
Welcome to the University of Pennsylvania
AIDS Clinical Trials Unit (ACTU) Homepage
The Penn ACTU carries out clinical trials studying new treatments against HIV infection, AIDS, and AIDS-related opportunistic infections. The Penn ACTU is a member of the AIDS Clinical Trials Group supported by funds from the National Institute of Allergy and Infection Diseases (NIAID) in Washington, D.C.
Ways to Treat HIV
There are now over 30 anti-HIV drugs available by prescription. They are usually prescribed as part of a three or four drug combination. Anti-HIV drug combinations are referred to as HAART, which stands for Highly Active Antiretroviral Therapy. Clinical trials have shown that HAART can work well in people who have been diagnosed with AIDS, as well as people who have HIV-related symptoms.
Click here to see info on - FDA approved HIV meds
If you would like more information about the trials at our site please check the trials button above or send a message through the feedback button. Also feel free to contact us through the methods provided below.Telephone 215-349-8092 FAX 215-349-8011 Postal address 502 Johnson Pavilion Philadelphia, PA 19104
BMC Medical Research Methodology at the 35th Annual Conference of the .. — BMC Pediatrics
The conference will focus on issues such as design and analysis of clinical trials, methods in biostatistics and development of clinical prediction models.
Does the European clinical trials directive really improve clinical trial approval time?
To facilitate and improve clinical research within Europe, the European Union (EU) adopted in 2001 the Clinical Trials Directive (EUCTD). The aim of this study was to compare duration between submission of a clinical drug trial application and approval by regulatory authorities in EU countries regulated by EUCTD vs. EU countries regulated by local legislation and, second, to compare the duration of regulatory approval in Europe vs. the USA and Australia.